A quasi‐experimental study evaluating the efficacy of crossmatch‐matched platelet transfusions in hemato‐oncology patients with suspected alloimmune platelet refractoriness: A single‐centre experience
Crossmatch-compatible platelet transfusions significantly improve post-transfusion CCI and PPR in alloimmunised hemato-oncology patients. Crossmatch compatibility and patient age were identified as two independent predictors of adequate early platelet transfusion response (1-h CCI, PPR and platelet increment).
Authors
- Gaurav Dhingra (ORCID: https://orcid.org/0000-0003-2578-529X)
- Abhishek Jain (ORCID: https://orcid.org/0000-0002-0116-1952)
- Daljit Kaur (ORCID: https://orcid.org/0000-0001-6587-652X)
- Vaidehi Prasanth (ORCID: https://orcid.org/0000-0001-6157-1446)
- Dixa Kumari
- Gita Negi
- Uttam Kumar Nath
- Joyisa Deb
Institutions
- Gauhati Medical College and Hospital (IN)
- All India Institute of Medical Sciences Bhopal (IN)
- All India Institute of Medical Sciences Rishikesh (IN)
- All India Institute of Medical Sciences Guwahati (IN)
- All India Institute of Medical Sciences (IN)
Publication Details
- Journal
- Transfusion Medicine
- Published
- 2026-01-22
- DOI
- https://doi.org/10.1111/tme.70058
- Primary Topic
- Blood transfusion and management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- All-India Institute of Medical Sciences